Company profile SRRK

Scholar Rock Holding Corp
scholar rock® is a biotechnology company focused on discovering and developing a new class of biologic therapies called "niche modulators" that selectively target the activation of growth factors in the disease microenvironment. our initial proprietary and partnered drug discovery programs target specific growth factors, including members of the tgf-beta superfamily, which pla...y a fundamental role in regulating cell growth and differentiation and are present in the microenvironments of significant diseases such as fibrosis, diseases of the musculoskeletal systems, and autoimmune diseases. the company’s therapeutic approach is enabled by discoveries made by scholar rock’s scientific founders—professors timothy springer, phd, and leonard zon, md, both of children's hospital boston and harvard medical school—related to the molecular mechanisms of growth factor activation. scholar rock is backed by leading life sciences investors, including polaris partners, arch venture partners, timothy s Show More
Quarter analysis & expected interest

There is not enough data for Scholar Rock Holding profile to provide analysis

Correlation between past revenue and Scholar Rock Holding profile search interest

There is not enough data for Scholar Rock Holding profile to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Scholar Rock Holding profile to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 19:58:14.

After 39 days of this quarter the interest is at 35.0. Based on that we can calculate that during remaining 52 days it will total up to 82.0.
Scholar Rock Holding expected interest is significantly lower compared to previous quarter (-62.7%) and same quarter last year (-67.1%).

YearQ1Q2Q3Q4
20190
39
inf% QoQ
202
417.9% QoQ
216
6.9% QoQ
2020 204
inf% YoY -5.6% QoQ
69
76.9% YoY -66.2% QoQ
339
67.8% YoY 391.3% QoQ
218
0.9% YoY -35.7% QoQ
2021 127
-37.7% YoY -41.7% QoQ
69
0.0% YoY -45.7% QoQ
135
-60.2% YoY 95.7% QoQ
34
-84.4% YoY -74.8% QoQ
2022 195
53.5% YoY 473.5% QoQ
116
68.1% YoY -40.5% QoQ
48
-64.4% YoY -58.6% QoQ
181
432.4% YoY 277.1% QoQ
2023 249
27.7% YoY 37.6% QoQ
105
-9.5% YoY -57.8% QoQ
65
35.4% YoY -38.1% QoQ
220
21.5% YoY 238.5% QoQ
2024 35
-85.9% YoY -84.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Scholar Rock Holding search interestLast update: February 09 2024 19:58:12.
Correlation coefficient between keyword and revenue is 0.14
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 19:58:15.

The average 5 years interest of Scholar Rock Holding was 10.98 per week.
The last year interest of Scholar Rock Holding compared to the last 5 years has changed by -8.56%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 0.0%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 19:58:22.

After 39 days of this quarter the interest is at 64.0. Based on that we can calculate that during remaining 52 days it will total up to 149.0.
Scholar Rock Holding stock expected interest is significantly higher compared to previous quarter (+104.1%) and same quarter last year (+60.2%).

YearQ1Q2Q3Q4
201924
129
437.5% QoQ
68
-47.3% QoQ
101
48.5% QoQ
2020 121
404.2% YoY 19.8% QoQ
96
-25.6% YoY -20.7% QoQ
25
-63.2% YoY -74.0% QoQ
83
-17.8% YoY 232.0% QoQ
2021 112
-7.4% YoY 34.9% QoQ
28
-70.8% YoY -75.0% QoQ
37
48.0% YoY 32.1% QoQ
47
-43.4% YoY 27.0% QoQ
2022 35
-68.8% YoY -25.5% QoQ
36
28.6% YoY 2.9% QoQ
46
24.3% YoY 27.8% QoQ
24
-48.9% YoY -47.8% QoQ
2023 93
165.7% YoY 287.5% QoQ
0
-100.0% YoY -100.0% QoQ
31
-32.6% YoY inf% QoQ
73
204.2% YoY 135.5% QoQ
2024 64
-31.2% YoY -12.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Scholar Rock Holding stock search interestLast update: February 09 2024 19:58:21.
Correlation coefficient between keyword and revenue is -0.03
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 19:58:23.

The average 5 years interest of Scholar Rock Holding stock was 4.88 per week.
The last year interest of Scholar Rock Holding stock compared to the last 5 years has changed by -21.52%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -38.13%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Scholar Rock Holding news to provide analysis

Correlation between past revenue and Scholar Rock Holding news search interest

There is not enough data for Scholar Rock Holding news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Scholar Rock Holding news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Scholar Rock Holding pharmaceuticals to provide analysis

Correlation between past revenue and Scholar Rock Holding pharmaceuticals search interest

There is not enough data for Scholar Rock Holding pharmaceuticals to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Scholar Rock Holding pharmaceuticals to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Scholar Rock Holding clinical trials to provide analysis

Correlation between past revenue and Scholar Rock Holding clinical trials search interest

There is not enough data for Scholar Rock Holding clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Scholar Rock Holding clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 19:58:29.

After 39 days of this quarter the interest is at 24.0. Based on that we can calculate that during remaining 52 days it will total up to 56.0.
Apitegromab expected interest is significantly lower compared to previous quarter (-62.9%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201996
166
72.9% QoQ
201
21.1% QoQ
138
-31.3% QoQ
2020 101
5.2% YoY -26.8% QoQ
71
-57.2% YoY -29.7% QoQ
61
-69.7% YoY -14.1% QoQ
123
-10.9% YoY 101.6% QoQ
2021 110
8.9% YoY -10.6% QoQ
187
163.4% YoY 70.0% QoQ
26
-57.4% YoY -86.1% QoQ
124
0.8% YoY 376.9% QoQ
2022 174
58.2% YoY 40.3% QoQ
20
-89.3% YoY -88.5% QoQ
89
242.3% YoY 345.0% QoQ
41
-66.9% YoY -53.9% QoQ
2023 84
-51.7% YoY 104.9% QoQ
41
105.0% YoY -51.2% QoQ
72
-19.1% YoY 75.6% QoQ
151
268.3% YoY 109.7% QoQ
2024 24
-71.4% YoY -84.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Apitegromab search interestLast update: February 09 2024 19:58:28.
Correlation coefficient between keyword and revenue is 0.45
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 19:58:30.

The average 5 years interest of Apitegromab was 8.05 per week.
The last year interest of Apitegromab compared to the last 5 years has changed by -31.18%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -54.06%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for SRK-181 to provide analysis

Correlation between past revenue and SRK-181 search interest

There is not enough data for SRK-181 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for SRK-181 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Scholar Rock Holding collaboration to provide analysis

Correlation between past revenue and Scholar Rock Holding collaboration search interest

There is not enough data for Scholar Rock Holding collaboration to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Scholar Rock Holding collaboration to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Scholar Rock Holding fibrotic diseases to provide analysis

Correlation between past revenue and Scholar Rock Holding fibrotic diseases search interest

There is not enough data for Scholar Rock Holding fibrotic diseases to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Scholar Rock Holding fibrotic diseases to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for SRRK
Earnings date: 2024-03-05 After close
Company name: Scholar Rock Holding Corp
Sector: Professional, Scientific, and Technical Services
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-08T15:49:04Z

Analyst Upgrades
Barclays Maintains Overweight on Scholar Rock Holding, Raises Price Target to $55

2026-05-08T11:20:59Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Scholar Rock Holding, Raises Price Target to $65

2026-05-07T11:00:00Z

BusinessWire
Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights

2026-04-29T12:00:00Z

BusinessWire
Scholar Rock to Present at the BofA Securities 2026 Health Care Conference

2026-04-24T16:05:11-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Scholar Rock Holding Corp (0001727196) (Issuer)

2026-04-21T15:50:47Z

Analyst Upgrades
Canaccord Genuity Initiates Coverage On Scholar Rock Holding with Buy Rating, Announces Price Target of $62

2026-04-17T20:15:00Z

BusinessWire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-04-16T12:00:00Z

BusinessWire
Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026

2026-04-01T12:38:42Z

Analyst Upgrades
Wedbush Maintains Outperform on Scholar Rock Holding, Raises Price Target to $58

2026-03-31T11:00:00Z

BusinessWire
Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)

2026-03-16T18:38:42Z

Analyst Upgrades
JP Morgan Maintains Overweight on Scholar Rock Holding, Raises Price Target to $50

2026-03-13T20:15:00Z

BusinessWire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-03-04T18:22:54Z

Analyst Upgrades
Citigroup Maintains Buy on Scholar Rock Holding, Raises Price Target to $58

2026-03-04T17:58:23Z

Analyst Upgrades
BMO Capital Maintains Outperform on Scholar Rock Holding, Raises Price Target to $70

2026-03-04T15:33:09Z

Analyst Upgrades
Truist Securities Maintains Buy on Scholar Rock Holding, Raises Price Target to $55